# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-036161
Filing Date
2025-04-28
Accepted
2025-04-28 17:05:28
Documents
19
Period of Report
2025-06-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | ea0237609-03.htm iXBRL | DEF 14A | 1336777
6 | GRAPHIC | tjoshua_sig.jpg | GRAPHIC | 12690
7 | GRAPHIC | tpaul-sig.jpg | GRAPHIC | 8507
8 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1387094
| Complete submission text file | 0001213900-25-036161.txt |  | 5399363

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL SCHEMA FILE | lgvn-20250428.xsd | EX-101.SCH | 10477
3 | XBRL DEFINITION FILE | lgvn-20250428_def.xml | EX-101.DEF | 3300
4 | XBRL LABEL FILE | lgvn-20250428_lab.xml | EX-101.LAB | 35387
5 | XBRL PRESENTATION FILE | lgvn-20250428_pre.xml | EX-101.PRE | 6772
21 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0237609-03_htm.xml | XML | 119397

Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40060 | Film No.: 25881447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)